Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.57	-302.76	412.34
Graham Fair Price	329.06	0.72	0.17
PEG	-99.68	-0.02	5.86
Price/Book	-28.30	8.57	11.96
Price/Cash Flow	-80.33	-259.99	1321.46
Prices/Earnings	95.71	-30.75	-717.20
Price/Sales	-15.47	11.54	13.66
Price/FCF	-80.33	-259.99	1321.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.36	0.34	0.40
Operating Margin	-175.98	-0.09	-0.03
ROA	-1522.21	-0.01	< 0.005
ROE	< 0.005	-0.07	-1572.34
ROIC	< 0.005	-0.02	-564.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	< 0.005	-58.99
Dividends QOQ	-0.19	0.05	-75.63
EBIT QOQ	-2.07	-1.22	41.06
EPS QOQ	-1.22	-16.39	-1239.92
FCF QOQ	-0.89	-4.46	-402.47
Revenue QOQ	-0.12	-0.20	-69.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.93	27.18	51.58
Days Sales Outstanding (DSO)	68.99	87.63	27.01
Inventory Turnover	5.02	3.31	-34.03
Debt/Capitalization	0.76	0.76	1.03
Quick Ratio	0.37	0.35	-6.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.55	0.57	4.92
Cash	0.18	0.14	-20.96
Capex	-0.01	< 0.005	47.96
Free Cash Flow	< 0.005	-0.02	282.37
Revenue	0.48	0.43	-11.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.42	0.41	-2.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	77.65	-78.25	0.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating